Rucaparib or Physician’s Choice in Metastatic Prostate Cancer

Author:

Fizazi Karim1,Piulats Josep M.1,Reaume M. Neil1,Ostler Peter1,McDermott Ray1,Gingerich Joel R.1,Pintus Elias1,Sridhar Srikala S.1,Bambury Richard M.1,Emmenegger Urban1,Lindberg Henriette1,Morris David1,Nolè Franco1,Staffurth John1,Redfern Charles1,Sáez María I.1,Abida Wassim1,Daugaard Gedske1,Heidenreich Axel1,Krieger Laurence1,Sautois Brieuc1,Loehr Andrea1,Despain Darrin1,Heyes Catherine A.1,Watkins Simon P.1ORCID,Chowdhury Simon1,Ryan Charles J.1,Bryce Alan H.1ORCID

Affiliation:

1. From Gustave Roussy Institute, Paris-Saclay University, Villejuif, France (K.F.); Institut Català d’Oncologia–Bellvitge Institute for Biomedical Research –CiberOnc, Barcelona (J.M.P.), and the Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga (M.I.S.) — both in Spain; the Ottawa Hospital Research Institute, Ottawa (M.N.R.), CancerCare Manitoba, Winnipeg (J.R.G.), and Princess Margaret Cancer Centre (S.S.S.) and Odette Cancer Centre, Sunnybrook...

Funder

Clovis Oncology

National Cancer Institute

Publisher

Massachusetts Medical Society

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3